Pressure BioSciences Inc. PBIO Archives - Page 10 of 22

TuesdayMay 05, 2020 9:32 am

QualityStocksNewsBreaks – Pressure BioSciences, Inc. (PBIO) Reveals Plan to Change Company Name to Availa Bio Upon Completion of Cannaworx, SkinScience Transactions

Pressure BioScience (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, cosmeceuticals, nutraceuticals, and food & beverage industries, today announced its plan to change the company’s name to Availa Bio upon completion of the acquisitions and merger of Cannaworx, Inc. and SkinScience Labs, Inc. The three companies will function as synergistic divisions within the combined "Availa Bio" entity, which will focus on optimizing bioavailability, absorption, quality and performance of human, animal and agricultural products. “PBI's UST platform offers the potential to deliver an extraordinary…

ThursdayApr 30, 2020 12:33 pm

QualityStocksNewsBreaks – Pressure BioSciences, Inc. (PBIO) Enters LOI to Acquire SkinScience Labs through Cannaworx

Pressure BioScience (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, cosmeceuticals, nutraceuticals, and food & beverage industries, today announced a letter of intent (“LOI”) to acquire SkinScience Labs, Inc., parent company of the award-winning Dr. Denese skin care and anti-aging product lines. Per the update, the rights to acquire SkinScience Labs, which includes Dr. Denese SkinScience, is through Cannaworx, Inc., for which PBI announced plans to acquire on April 28, 2020. “The Dr. Denese SkinScience brand has reached top performing status on QVC…

WednesdayApr 29, 2020 9:18 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Inks Binding LOI to Acquire Cannaworx, Inc.

Pressure BioScience (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform-technology solutions to the worldwide life sciences and other industries, today announced that it has signed a binding letter of intent (“LOI”) to merge with Cannaworx, Inc. (USA) and its diverse portfolio of products and intellectual property. The merger will combine Cannaworx's proprietary portfolio of consumer products with the application of PBIO's breakthrough ultra shear technology (“UST”). Following the merge, the company will utilize its extensive intellectual property portfolio, consisting of a proprietary pressure platform, nanotechnology and advanced delivery systems, to disrupt…

ThursdayApr 16, 2020 2:39 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) and RedShiftBio Combine Proprietary Technology to Create Powerful Biotherapeutic Drug Development Platform

Pressure BioScience (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform-technology solutions to the worldwide life sciences and other industries, today announced that the combination of PBIO's patented Pressure Cycling Technology ("PCT") with RedShiftBio's proprietary Microfluidic Modulation Spectroscopy ("MMS") has resulted in a powerful new platform for biotherapeutic drug development ("PCT-enhanced MMS"). PBIO believes combining both platforms enables for the rigorous investigation of protein structure and stability in a highly efficient workflow that can be crucial in drug development. Per the release, the collaboration should result in faster development of new drugs…

FridayMar 20, 2020 12:29 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc.’s (PBIO) UST Demonstration Laboratory Showcases Groundbreaking Technology

Pressure BioScience (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform-technology solutions to the worldwide life sciences and other industries, recently announced the opening of its new Ultra Shear Technology(TM) (“UST”) Demonstration Laboratory (http://ibn.fm/veoMI). An article discussing the company reads, “The main goal of the UST Demo Lab is to showcase the ability of the company’s revolutionary UST Platform to process cannabidiol (‘CBD’) oil into water-soluble nanoemulsions of superior quality. CBD nanoemulsions are expected to be more stable and offer higher bioavailability than the standard macro and microemulsions used in the vast…

ThursdayMar 12, 2020 9:42 am

QualityStocksNewsBreaks – Pressure BioSciences, Inc. (PBIO) Receives Order for Game-Changing UST System from Can B Corp. (CANBD)

Pressure BioScience (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences and other industries, today announced its receipt of a purchase order from a new customer, Can B Corp. (OTCQB: CANBD). According to the update, the order is for one of PBIO’s proprietary BaroShear K45 Ultra Shear Technology(TM) ("UST")-based systems for processing CBD oil into stable, effectively water-soluble, highly absorbable nanoemulsions of oil in water. The nanoemulsions are expected to exhibit bioavailability levels that far exceed the absorption efficiency of today's macro or microemulsions of…

TuesdayMar 10, 2020 12:07 pm

Pressure BioSciences Inc. (PBIO) Opens UST Demonstration Lab, Ushering in New Era in CBD Water-Soluble Nanoemulsion Preparation

The new facility is designed to demonstrate the company’s innovative Ultra Shear Technology’s ability to create CBD oil nanoemulsions of superior stability, aesthetics, and bioavailability Company has received orders for nine UST-based BaroShear K45 proprietary systems, with three more anticipated shortly, for an overall value of $2.4 million Global nanoemulsion market estimated to rise to $14.91 billion by the end of 2025 Pressure BioSciences Inc. (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, and other industries, recently announced the opening of their new Ultra…

ThursdayFeb 27, 2020 11:07 am

QualityStocksNewsBreaks – Pressure BioSciences, Inc. (PBIO) Announces Official Opening of its Ultra Shear Technology(TM) Demonstration Laboratory

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics and other industries, today announced the official opening of its new Ultra Shear Technology(TM) ("UST") Demonstration Laboratory. According to the update, the major purpose of the UST Demo Lab, located in the company's South Easton, Massachusetts facility, is to showcase the ability of the company's revolutionary UST Platform to process CBD oil into true, high quality, water-soluble nanoemulsions. A second purpose is to invite potential purchasers of Pressure BioSciences’ UST-based BaroShear Systems (initial release…

FridayFeb 07, 2020 12:28 pm

QualityStocksNewsBreaks – Pressure BioSciences, Inc. (PBIO) Featured in Updated Research Report by Zacks SCR

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences industry, today announced that Zacks Small Cap Research ("Zacks SCR") has released an updated research report in its on-going coverage on the Company. Copies of the new Zacks SCR report are available via the following link: http://ibn.fm/n3zPF To view the full press release, visit http://ibn.fm/eTnSG About Pressure BioSciences Inc. Pressure BioSciences is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. The company’s products are…

ThursdayJan 30, 2020 11:45 am

QualityStocksNewsBreaks – Pressure BioSciences, Inc. (PBIO) Announces Plans to Release Benchtop UST-Based BaroShear Instrument in Q3 2020

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences and other industries, today announced its plans to release a benchtop, R&D scale, Ultra Shear Technology(TM) (“UST”)-based BaroShear instrument to the market in the third quarter of 2020. Per the update, Pressure BioSciences believes this new instrument will address a significant un-met need in product formulation and development laboratories throughout cannabis, cosmetics, nutraceuticals, pharmaceuticals, and other large and diverse markets for processing CBD and other oils into stable, effectively water-soluble, highly absorbable nanoemulsions of…

Site Search

Company Search

Tag: Pressure BioSciences Inc. PBIO